Furthermore, when the COLO 205 tumor line was exposed to a known RSK2 inhibitor (SL0101 at low concentration), increased clonogenic activity was observed; thereby implying RSK2 might, at least, play a role in promoting clonogenicity. This evidence concerns the gene RPS6KA3 and neoplasm.